Two samples displayed weak signals for TFE3 in dedifferentiated liposarcoma among control tumours, and 88% of SFT samples showed a strong presence of TFE3 indicating that TFE3 can act as a potential marker for the diagnosis of SFT. This evidence concerns the gene TFE3 and liposarcoma.